{
  "id": "d301fda7f13ba2d6",
  "title": "AI - discovered IL - 17 inhibitor shows best - in - class potential",
  "description": "20251215T173000Z",
  "content": "",
  "source": "europeanpharmaceuticalreview.com",
  "source_url": "https://www.europeanpharmaceuticalreview.com/news/269358/ai-discovered-il-17-inhibitor-ascletis-pharma-best-in-class-potential/",
  "published_at": "20251215T173000Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "United Kingdom",
  "raw_data": {
    "url": "https://www.europeanpharmaceuticalreview.com/news/269358/ai-discovered-il-17-inhibitor-ascletis-pharma-best-in-class-potential/",
    "url_mobile": "",
    "title": "AI - discovered IL - 17 inhibitor shows best - in - class potential",
    "seendate": "20251215T173000Z",
    "socialimage": "https://www.europeanpharmaceuticalreview.com/wp-content/uploads/shutterstock_1216280998-e1631095743520.jpg",
    "domain": "europeanpharmaceuticalreview.com",
    "language": "English",
    "sourcecountry": "United Kingdom"
  }
}